Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten L Simoons

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
The American Journal of Medicine|August 26, 2003
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trialStefan James, Paul Armstrong, Robert Califf, et al.
Circulation|February 5, 2003
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromesChristopher Heeschen, Stefanie Dimmeler, Christian W Hamm, et al.
The American Journal of Cardiology|January 12, 2005
Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathyDominic A M J Theuns, A Peter J Klootwijk, Maarten L Simoons, et al.
Critical Pathways in Cardiology|August 31, 2010
Evaluation of a clinical decision support system for glucose control: impact of protocol modifications on compliance and achievement of glycemic targetsJonathan A Lipton, Rogier J Barendse, K Martijn Akkerhuis, et al.
American Heart Journal|May 8, 2004
Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?Moti Haim, Alexander Battler, Solomon Behar, et al.
Cardiovascular Drugs and Therapy|October 22, 2008
Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?Willem J Remme, Jaap W Deckers, Kim M Fox, et al.
American Heart Journal|February 5, 2004
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudyStefan K James, Agneta Siegbahn, Paul Armstrong, et al.
Journal of Electrocardiology|May 11, 2004
Reconstruction of the 12-lead electrocardiogram from reduced lead setsStefan P Nelwan, Jan A Kors, Simon H Meij, et al.
Plos One|November 11, 2011
Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008Sjoerd T Nauta, Jaap W Deckers, Martijn Akkerhuis, et al.
American Heart Journal|May 4, 2010
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA studyMichel E Bertrand, Roberto Ferrari, Wilhelm J Remme, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
The American Journal of Medicine|August 26, 2003
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trialStefan James, Paul Armstrong, Robert Califf, et al.
Circulation|February 5, 2003
Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromesChristopher Heeschen, Stefanie Dimmeler, Christian W Hamm, et al.
The American Journal of Cardiology|January 12, 2005
Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathyDominic A M J Theuns, A Peter J Klootwijk, Maarten L Simoons, et al.
Critical Pathways in Cardiology|August 31, 2010
Evaluation of a clinical decision support system for glucose control: impact of protocol modifications on compliance and achievement of glycemic targetsJonathan A Lipton, Rogier J Barendse, K Martijn Akkerhuis, et al.
American Heart Journal|May 8, 2004
Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?Moti Haim, Alexander Battler, Solomon Behar, et al.
Cardiovascular Drugs and Therapy|October 22, 2008
Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?Willem J Remme, Jaap W Deckers, Kim M Fox, et al.
American Heart Journal|February 5, 2004
Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudyStefan K James, Agneta Siegbahn, Paul Armstrong, et al.
Journal of Electrocardiology|May 11, 2004
Reconstruction of the 12-lead electrocardiogram from reduced lead setsStefan P Nelwan, Jan A Kors, Simon H Meij, et al.
Plos One|November 11, 2011
Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008Sjoerd T Nauta, Jaap W Deckers, Martijn Akkerhuis, et al.
American Heart Journal|May 4, 2010
Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA studyMichel E Bertrand, Roberto Ferrari, Wilhelm J Remme, et al.
Pageof 19